Search & Filter

A new poll of medical experts has highlighted how the knock-on effect of lack of planning for old age will further impact upon stretched NHS resources.

Despite the initial slow uptake of Novel Oral Anticoagulants (NOACs), they will still challenge warfarin as a viable treatment for Venous Thromboembolism (VTE), consulting firm GlobalData has predicted.

Patients with no schooling benefit least from blood thinning medications, reveals a European Heart Rhythm Association (EHRA)/European Society of Cardiology (ESC) survey published  in Europace. The poll of more than 1100 patients with atrial fibrillation found those with no schooling missed treatment targets more often, were less aware of bleeding risks, and did not know they could continue normal daily activities.

The drug romosozumab has posted positive results in the Phase 3 placebo-controlled FRActure study in postmenopausal woMen with ostEoporosis (FRAME) trial, according to UCB and Amgen.

Patients with higher education benefit more from blood thinning medications, a new study by the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) has revealed.

The first European advice on emergency care for patients with acute heart failure has been published in European Heart Journal: Acute Cardiovascular Care.

A new survey has highlighted that the lack of engagement with specialist services of some patients with multiple sclerosis (MS) is a concern for MS-specialists.

The recent announcement that Merck and ImmunoGen will partner to investigate a combination of their respective drugs, Keytruda and mirvetuximab soravtansine, for the treatment of ovarian cancer, will "open the way to unlocking the potential of combining novel immuno-oncology (IO) and non-IO drugs", according to a specialist oncology analyst.

The recent announcement that Merck and ImmunoGen will partner to investigate a combination of their respective drugs, Keytruda and mirvetuximab soravtansine, for the treatment of ovarian cancer, will "open the way to unlocking the potential of combining novel immuno-oncology (IO) and non-IO drugs", according to a specialist oncology analyst.

A new survey has highlighted that the lack of engagement with specialist services of some patients with multiple sclerosis (MS) is a concern for MS-specialists.

Smoking has been linked to a worsening degenerative disc disease in the cervical spine, researchers at Emory University in Atlanta, Georgia, have announced.

Microscopic alterations in brain wiring within regions of the brain that underlie reasoning and awareness could be responsible for the association between childhood IQ, low birthweight and later psychotic experiences, new research has claimed.

The European Medicine Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has concluded three reviews into the drug safety at its February meeting.

More than 352,000 people are diagnosed with cancer in the UK each year, 12% increase in the rate since the mid-nineties, according to new figures released by Cancer Research UK.

Around 7,100 women are diagnosed in the UK with ovarian cancer each year. Read the latest on developments in the diagnosis and management of ovarian cancer.